PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS. (12th June 2019) - Melani, C.J.; Lakhotia, R.; Pittaluga, S.; Miljkovic, M.D.; Portell, C.A.; Farah, R.J.; Juanitez, A.M.; Chou, L.L.; Steinberg, S.M.; Jaffe, E.S.; Staudt, L.M.; Roschewski, M.J.; et al.